Project Grant T32TR005456
- The National Center for Advancing Translational Sciences at the National Institutes of Health awarded Georgetown University $206,908 on September 1, 2026, under the CTSA Postdoctoral T32 Program (CFDA 93.350) to support a two-year translational biomedical science training program for postdoctoral fellows. Georgetown University leads the Georgetown-Howard Universities Center for Clinical and Translational Sciences (GHUCCTS), a multi-institutional partnership also comprising Howard University,...
- The National Center for Advancing Translational Sciences awarded a cooperative agreement to Georgetown University for $3.969 million on August 4, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350). Georgetown University leads the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS), a multi-institutional partnership that includes Howard University, MedStar Health Research Institute, the Washington DC Veterans...
- The National Center for Advancing Translational Sciences awarded Georgetown University $752,548 on September 1, 2026, under the CTSA K12 Program (CFDA 93.350) to support clinical and translational science training and career development for early-stage investigators. Georgetown University operates the K12 program as part of the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS), a partnership that includes Howard University, MedStar Health Research...
- The National Institute of General Medical Sciences awarded Georgetown University $471,337 on July 18, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support medical scientist training in the Georgetown University Medical Science Training Program. The award funds four Medical Science Training Program trainees per year during their first two years of enrollment, providing a total of eight training slots over the initial phase. Trainees receive instruction in...
- The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health awarded New York University $462,079 on September 1, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to support a postdoctoral training program in translational science. The NYU CTSI T32 Postdoctoral Training Program equips postdoctoral scholars with knowledge, skills, and abilities to lead interdisciplinary teams spanning pre-clinical research,...
- The National Center for Advancing Translational Sciences at the National Institutes of Health awarded a cooperative agreement to New York University on March 20, 2026, obligating $38.325 million under CFDA 93.350 (National Center for Advancing Translational Sciences). The award funds the New York University Clinical and Translational Science Institute (CTSI) hub, which will enhance community-engaged research, democratize health informatics resources, develop a well-rounded translational...
- The National Center for Advancing Translational Sciences awarded Johns Hopkins University $1,644,144 on September 15, 2025, under the CTSA Postdoctoral T32 program (CFDA 93.350) to operate an integrated postdoctoral training program in clinical and translational research through August 31, 2030. The program delivers mentored training in translational science core principles, biodesign methodology and research applications, and community engagement skills to postdoctoral trainees. The...
- The National Center for Advancing Translational Sciences awarded the University of Texas Medical Branch at Galveston $711,020 on September 1, 2026, under the NCATS program (CFDA 93.350) to establish and operate the Greater Gulf Coast Translational Science Alliance (GGCTSA) K12 Scholars Program. The program delivers career development training in translational science skills and principles to early-career research faculty through cooperative mentoring by an alliance of four Houston-area...
- The National Center for Advancing Translational Sciences awarded the University of Massachusetts Medical School $328,040 on August 15, 2026, under the CTSA Predoctoral T32 training program (Assistance Listing 93.350) to develop a two-year predoctoral training program in clinical and translational science. The program will recruit three cohorts of six doctoral students with guaranteed funding across rigorous doctoral programs in nursing, MD/PhD, population health sciences, epidemiology,...
- The National Institutes of Health National Center for Advancing Translational Sciences awarded the University of Pennsylvania $532,701 on July 6, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to support a postdoctoral training program in clinical and translational science. The award funds the CTSA Postdoctoral T32 at Penn, which trains clinical and translational science investigators to move scientific discoveries from the laboratory into clinical...
The National Center for Advancing Translational Sciences at the National Institutes of Health awarded Georgetown University $181,747 on August 7, 2026, under the NCATS program (CFDA 93.350) to support a predoctoral training program in translational biomedical science. Georgetown University, in partnership with Howard University, MedStar Health Research Institute, the Washington DC Veterans Administration Medical Center, and Oak Ridge National Laboratory, operates the Georgetown-Howard Universities Center for Clinical and Translational Science. The award funds a two-year Translational Biomedical Science training program for predoctoral students at Georgetown and Howard who have advanced to candidacy in biomedical sciences. The program trains approximately 36 students annually in clinical and translational research skills. Alumni from the prior decade-long program authored 57 papers, 143 abstracts, and 55 successful extramural grants, and received 70 research recognition awards at scientific meetings. Performance occurs in Washington, DC 20057. The period of performance extends from August 7, 2026, through May 31, 2031. This assistance type is a Project Grant. The program's mission is to transform the translational science process to deliver new treatments, cures, diagnostics, and medical devices to patients faster by reducing bottlenecks in the translational research pipeline.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $181.7k | 8/6/26 |